• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓性血小板减少性紫癜伴大、小缺血性脑卒中患者的生物标志物鉴定。

Identification of Biomarkers in Patients with Thrombotic Thrombocytopenic Purpura Presenting with Large and Small Ischemic Stroke.

机构信息

Department of Neurology, The University of Alabama at Birmingham, Birmingham, Alabama, USA,

Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

出版信息

Cerebrovasc Dis Extra. 2021;11(1):29-36. doi: 10.1159/000513574. Epub 2021 Feb 18.

DOI:10.1159/000513574
PMID:33601375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7989830/
Abstract

BACKGROUND

Thrombotic thrombocytopenic purpura (TTP) is a rare blood disorder resulting in organ damage including ischemic strokes. We sought to characterize the neuroimaging patterns of stroke in a large cohort of patients with immune-mediated TTP (iTTP) and determined their associations with clinical and laboratory parameters and outcomes.

METHODS

We analyzed the Alabama TTP Registry who had laboratory confirmation of acute iTTP. We reviewed the neuroimaging patterns of those with ischemic stroke on MRI, clinical information, and laboratory results. Small ischemic strokes were ≤20 mm in their maximum diameter in the axial plane. Large ischemic strokes were >20 mm. Student t test, Mann-Whitney U test, and χ2 test were all used for data analysis.

RESULTS

Of 108 iTTP patients, 21 had ischemic stroke on neuroimaging. The median platelet count in these patients was 12 × 109/L (interquartile range, IQR, 8.8-21 × 109/L), plasma ADAMTS13 activity 1.8 U/dL (IQR 0-4.5 U/dL), and the mean plasma level of anti-ADAMTS13 IgG was 6,595.8 U/mL (SD 3,448.9 U/mL). Comparison between patients with large ischemic strokes (n = 10) and small ischemic strokes (n = 11) revealed that patients with small stroke were older (p = 0.043) and had higher plasma levels of citrullinated histone 3 (p = 0.006) and histone/DNA complex (p = 0.014) than those with large strokes. There were no significant differences between 2 stroke groups in mortality or exacerbation.

CONCLUSIONS

iTTP patients can present with large ischemic strokes and are usually younger. Further research should be performed in assessing different etiologies of iTTP-associated stroke based on neutrophil extracellular trap formation biomarkers (e.g., histone markers) seen in small ischemic stroke.

摘要

背景

血栓性血小板减少性紫癜(TTP)是一种罕见的血液疾病,可导致包括缺血性中风在内的器官损伤。我们旨在对大量免疫介导性 TTP(iTTP)患者的中风神经影像学模式进行特征描述,并确定其与临床和实验室参数及结果的相关性。

方法

我们分析了阿拉巴马 TTP 登记处的实验室确诊的急性 iTTP 患者。我们对 MRI 显示缺血性中风的患者的神经影像学模式、临床信息和实验室结果进行了回顾。小面积缺血性中风的最大直径在轴向平面上小于 20mm;大面积缺血性中风的最大直径大于 20mm。所有数据分析均采用学生 t 检验、Mann-Whitney U 检验和 χ2 检验。

结果

在 108 例 iTTP 患者中,21 例在神经影像学上出现缺血性中风。这些患者的血小板计数中位数为 12×109/L(四分位距,IQR,8.8-21×109/L),血浆 ADAMTS13 活性为 1.8 U/dL(IQR 0-4.5 U/dL),抗 ADAMTS13 IgG 的平均血浆水平为 6595.8 U/mL(标准差 3448.9 U/mL)。大缺血性中风组(n=10)和小缺血性中风组(n=11)患者之间的比较显示,小中风患者年龄更大(p=0.043),且血浆瓜氨酸化组蛋白 3(p=0.006)和组蛋白/DNA 复合物(p=0.014)水平更高。2 个中风组在死亡率或恶化方面无显著差异。

结论

iTTP 患者可出现大的缺血性中风,且通常更年轻。应进一步研究基于中性粒细胞胞外诱捕网形成生物标志物(如组蛋白标志物)评估 iTTP 相关中风的不同病因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/7989830/5360631dfe8b/cee-0011-0029-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/7989830/5360631dfe8b/cee-0011-0029-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab26/7989830/5360631dfe8b/cee-0011-0029-g01.jpg

相似文献

1
Identification of Biomarkers in Patients with Thrombotic Thrombocytopenic Purpura Presenting with Large and Small Ischemic Stroke.血栓性血小板减少性紫癜伴大、小缺血性脑卒中患者的生物标志物鉴定。
Cerebrovasc Dis Extra. 2021;11(1):29-36. doi: 10.1159/000513574. Epub 2021 Feb 18.
2
Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura.血浆 ADAMTS13 生物标志物的纵向评估可预测免疫性血栓性血小板减少性紫癜的复发。
Blood Adv. 2019 Dec 23;3(24):4177-4186. doi: 10.1182/bloodadvances.2019000939.
3
Plasma levels of S100A8/A9, histone/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura.血浆 S100A8/A9、组蛋白/DNA 复合物和游离细胞 DNA 水平预测免疫性血栓性血小板减少性紫癜的不良结局。
J Thromb Haemost. 2021 Feb;19(2):370-379. doi: 10.1111/jth.15176. Epub 2021 Jan 3.
4
Immune-Thrombotic Thrombocytopenic Purpura is a Rare Cause of Ischemic Stroke in Young Adults: Case Reports and Literature Review.免疫性血栓性血小板减少性紫癜是青年缺血性卒中的罕见病因:病例报告及文献综述
J Stroke Cerebrovasc Dis. 2018 Nov;27(11):3163-3171. doi: 10.1016/j.jstrokecerebrovasdis.2018.07.017. Epub 2018 Sep 12.
5
Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura.急性免疫介导性血栓性血小板减少性紫癜患者的缺血性脑卒中主要特征。
Thromb Res. 2024 Nov;243:109151. doi: 10.1016/j.thromres.2024.109151. Epub 2024 Sep 13.
6
ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpura.ADAMTS13特异性循环免疫复合物作为获得性血栓性血小板减少性紫癜患者复发的潜在预测指标。
Eur J Intern Med. 2017 Apr;39:79-83. doi: 10.1016/j.ejim.2016.11.003. Epub 2016 Nov 22.
7
Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura.免疫介导性血栓性血小板减少性紫癜的发病率、诊断和转归:西班牙血栓性血小板减少性紫癜登记处的全国性调查。
J Clin Apher. 2021 Aug;36(4):563-573. doi: 10.1002/jca.21894. Epub 2021 Mar 29.
8
Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura.激活的 ADAMTS13,由抗体诱导,是亚临床免疫介导性血栓性血小板减少性紫癜的生物标志物。
Blood. 2020 Jul 16;136(3):353-361. doi: 10.1182/blood.2019004221.
9
Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study.免疫介导的血栓性血小板减少性紫癜患者伴或不伴系统性红斑狼疮:一项回顾性研究。
Orphanet J Rare Dis. 2020 Aug 28;15(1):225. doi: 10.1186/s13023-020-01510-9.
10
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.ADAMTS13和抗ADAMTS13抗体作为获得性血栓性血小板减少性紫癜缓解期复发的标志物。
Haematologica. 2008 Feb;93(2):232-9. doi: 10.3324/haematol.11739. Epub 2008 Jan 26.

引用本文的文献

1
Recurrent Multi-territorial Ischemic Stroke As the Initial Presentation of Thrombotic Thrombocytopenic Purpura.复发性多区域缺血性卒中作为血栓性血小板减少性紫癜的初始表现
Cureus. 2025 Feb 17;17(2):e79155. doi: 10.7759/cureus.79155. eCollection 2025 Feb.
2
Targeting Neutrophil Extracellular Traps for Stroke Prognosis: A Promising Path.以中性粒细胞胞外诱捕网为靶点改善卒中预后:一条充满希望的途径。
Neurol Int. 2023 Sep 28;15(4):1212-1226. doi: 10.3390/neurolint15040076.
3
Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course.
血栓性微血管病的神经表现:影像学特征、危险因素和临床病程。
PLoS One. 2022 Sep 21;17(9):e0272290. doi: 10.1371/journal.pone.0272290. eCollection 2022.
4
Systemic sclerosis complicated with renal thrombotic microangiopathy: a case report and literature review.系统性硬皮病并发肾血栓性微血管病:病例报告及文献复习。
BMC Nephrol. 2022 Jan 10;23(1):22. doi: 10.1186/s12882-021-02639-w.
5
The standard of care for immune thrombotic thrombocytopenic purpura today.目前免疫性血栓性血小板减少性紫癜的治疗标准。
J Thromb Haemost. 2021 Aug;19(8):1864-1871. doi: 10.1111/jth.15406. Epub 2021 Jun 30.
6
Cerebral Infarction in Immune Thrombotic Thrombocytopenic Purpura Is Associated with Old Age, Hypertension, Smoking, and Anti-ADAMTS13 Ig, But Not with Mortality.免疫性血栓性血小板减少性紫癜中的脑梗死与老年、高血压、吸烟及抗ADAMTS13免疫球蛋白有关,但与死亡率无关。
TH Open. 2021 Jan 13;5(1):e1-e7. doi: 10.1055/s-0040-1722610. eCollection 2021 Jan.